FIELD: diagnostics.
SUBSTANCE: invention relates to a method for preparing a tumor tissue sample. A method for preparing a tumor tissue sample for determining a phenotypic profile of a tumor tissue sample, which involves: homogenisation of a tumor tissue sample; reconstructing a homogenized sample to obtain a homogenate, wherein said homogenate comprises substantially homogeneous cell structures, where the ratio of the cell structures in the homogenate subgroup is substantially similar or equal to the ratio of the cell structures in the tissue sample; analysis of homogenate cell structures; determining phenotypic profile of tumor tissue.
EFFECT: method described above enables higher detection of mutations from cancer tissues compared to histological sections taken from FFPE units of the same tissue.
1 cl, 55 dwg, 24 tbl, 12 ex
Title | Year | Author | Number |
---|---|---|---|
AXL SIGNALLING INHIBITION IN ANTIMETASTATIC THERAPY | 2011 |
|
RU2556822C2 |
METHODS BASED ON DETECTING RAD51 FOCI IN TUMOUR CELLS | 2018 |
|
RU2825699C2 |
METHOD FOR MULTI ANALYSES OF RARE CELLS EXTRACTED OR ISOLATED FROM BIOLOGICAL SAMPLES BY FILTERING | 2013 |
|
RU2641595C2 |
IDENTIFICATION OF TUMOUR-ASSOCIATED ANTIGENS FOR DIAGNOSTICS AND THERAPY | 2013 |
|
RU2644686C2 |
METHOD FOR CONDUCTING MULTI-ASSAYS OF RARE CELLS EXTRACTED OR ISOLATED FROM BIOLOGICAL SAMPLES BY FILTRATION | 2013 |
|
RU2765808C2 |
COMBINED THERAPY WITH CLAUDINE 18.2 ANTIBODIES FOR CANCER TREATMENT | 2014 |
|
RU2699549C2 |
ANTIBODIES AGAINST CLAUDIN 18.2 FOR CANCER DIAGNOSIS | 2013 |
|
RU2661772C2 |
INDIVIDUALISED VACCINES FOR CANCER | 2012 |
|
RU2670745C9 |
INDIVIDUALIZED ANTI-TUMOR VACCINES | 2012 |
|
RU2779946C2 |
MONOCLONAL ANTI-CLAUDIN-18 ANTIBODIES FOR TREATING CANCER | 2008 |
|
RU2571923C2 |
Authors
Dates
2021-02-15—Published
2016-11-07—Filed